Similar to LDL cholesterol add-back, administering recombinant insulin, IGF1 and leptin to Capan-1 xenograft-bearing mice abolished fasting-induced enhancement of terbinafine activity (Fig. 3e, f) and it also restored cholesterol content in the tumours (Fig. 3g). This evidence concerns the gene LEP and neoplasm.